摘要
目的从多方面评估体外热电场治疗对男性慢性前列腺炎/慢性盆腔疼痛综合征(CP/CPPS)患者症状的改善情况并进行疗效分析,进而判断其临床应用价值。方法回顾性收集2018年4月至2019年3月,57例使用LR-2005体外热电场治疗机进行治疗的CP/CPPS患者的临床资料,并对其治疗前后所填评分量表进行统计学分析。患者20~50岁,病程3个月~7年,其中行1个疗程治疗17例,2个疗程32例,3个疗程8例。所用评分量表包括:NIH-CPSI评分、PUF评分、VAS评分、QOL评分、SAS评分、SDS评分等。结果治疗前与治疗后,患者NIH-CPSI总评分分别为(25.05±6.32)vs(19.54±6.16)、PUF症状评分为(10.86±4.41)vs(8.46±4.11)、PUF困扰评分为(5.35±2.88)vs(4.03±2.33)、VAS评分为(3.97±2.40)vs(2.03±1.85)、QOL评分为(4.89±1.27)vs(3.95±1.25)、SAS评分为(37.35±8.76)vs(34.00±8.14)、SDS评分为(34.41±7.43)vs(32.05±4.78),治疗后均下降且与治疗前比较差异具有显著统计学意义(P<0.01)。治疗后NIHCPSI评分轻中度人数增加,重度人数明显减少,治疗前后差异具有显著统计学意义(P<0.01)。患者治疗后未见特殊不适或不良反应发生。结论体外热电场治疗能够有效减轻CP/CPPS患者炎症和疼痛反应,改善排尿症状,降低焦虑抑郁程度,提高患者生活质量。其临床疗效显著,治疗有效率高,符合WHO倡导的“无痛、无创、非介入”的治疗模式,患者容易接受,值得临床推广。
Objective To evaluate the improvement of symptoms in patients with chronic prostatitis/chronic pelvic pain syndrome(CP/CPPS)treated by thermoelectric field therapy.Methods From April 2018 to March 2019,57 CP/CPPS patients treated by LR-2005 thermoelectric field therapeutic Machine.The patients were aged 20-50 years,and the course of the disease was ranged from 3 months to 7 years.Among them,17 patients with one period of therapy,32 patients with two period of therapy,and the rest with three.Each patient underwent clinical assessment and answered the questionnaire consisted of NIH-CPSI,PUF,VAS,QOL,SAS and SDS.Compared and analyzed the scores statistically.Results After treatment,the NIH-CPSI total score[(25.05±6.32)vs(19.54±6.16)],PUF symptom score[(10.86±4.41)vs(8.46±4.11)],PUF distress score[(5.35±2.88)vs(4.03±2.33)],VAS score[(3.97±2.40)vs(2.03±1.85)],QOL score[(4.89±1.27)vs(3.95±1.25)],SAS score[(37.35±8.76)vs(34.00±8.14)],SDS score[(34.41±7.43)vs(32.05±4.78)]were all decreased significantly(P<0.01).The NIH-CPSI score increased in numbers of mild and moderate,while the severe decreased significantly(P<0.01).No special discomfort or adverse reactions occurred after treatment.Conclusion Thermoelectric field therapy can effectively alleviate inflammation and pain response,improve voiding symptoms,reduce anxiety and depression of CP/CPPS patients,and improve the quality of life.Its clinical curative effect is remarkable,and it fits the"painless,non-invasive and non-interventional"treatment model advocated by WHO.It was worth of promoting in clinical application.
作者
丁虹璐
冯经纬
吴珍
陈嘉良
刘柏隆
林志钧
谢俊聪
许源城
周祥福
Ding Honglu;Feng Jingwei;Wu Zhen;Chen Jialiang;Liu Bolong;Lin Zhijun;Xie Juncong;Xu Yuancheng;Zhou Xiangfu(Department of Urology,the Third Affliated Hospital of Sun Yat-sen University,Guangzhou 510630,China)
出处
《中华腔镜泌尿外科杂志（电子版）》
2020年第1期56-60,共5页
Chinese Journal of Endourology(Electronic Edition)
基金
国家自然科学基金(81670688、81800666)
广东省自然科学基金(2016A030313192、2017A030310414、2018A0303130330)
广东省医学科学技术研究基金项目(A2017365)
高校基本科研业务费-青年教师培育项目(19ykpy33)。
